Trials / Recruiting
RecruitingNCT06730451
Microbiota Transplantation in Solid Organ Transplantation
Washed Microbiota Transplantation for Postoperative Complications in Solid Organ Transplantation
- Status
- Recruiting
- Phase
- —
- Study type
- Observational
- Enrollment
- 50 (estimated)
- Sponsor
- The Second Hospital of Nanjing Medical University · Academic / Other
- Sex
- All
- Age
- —
- Healthy volunteers
- Not accepted
Summary
Solid organ transplantation (SOT), an alternative therapy for end-stage diseases, offers increased longevity and better quantity of life. Posttransplant complications such as gastrointestinal symptoms, infection, and graft rejection increase risk with graft failure and death. However, the treatment of abovementioned complications remains unsatisfactory. Gut dysbiosis has been reported in patients with SOT, especially in patients with posttransplant complications. Recipients are more susceptible to gut dysbiosis as long-term use of immunosuppressants, antibiotics and corticosteroids. Restoring gut microbiome may be a promising therapy for posttransplant complications. Washed microbiota transplantation (WMT) is a newly improved methodology of fecal microbiota transplantation based on automatic facilities, washing process and a new delivery routine. In this study, investigators aimed to evaluate the efficacy and safety of WMT for postoperative complications in SOT.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| OTHER | Washed Microbiota Transplantation | Washed microbiota suspension delivered through mild-gut and lower-gut |
Timeline
- Start date
- 2018-01-01
- Primary completion
- 2027-12-31
- Completion
- 2028-12-31
- First posted
- 2024-12-12
- Last updated
- 2024-12-12
Locations
1 site across 1 country: China
Source: ClinicalTrials.gov record NCT06730451. Inclusion in this directory is not an endorsement.